HoFH CASCADE Registry

Mary P. McGowan, MD, chief medical officer of the Family Heart Foundation provides an overview of the CASCADE registry focused on patients with homozygous familial hypercholesterolemia (HoFH).     HoFH is a rare genetic disorder that results in severe...

SORD Deficiency Explained

Shoshana Shendelman, PhD, President and Chief Executive Officer of Applied Therapeutics, provides an overview of sorbitol dehydrogenase (SORD) deficiency.     SORD Deficiency is a rare genetic disorder that affects the body’s ability to metabolize...

Gaucher Disease: Diagnosis and Awareness

Gaucher disease (GD) is a rare, autosomal recessive lysosomal storage disorder, in which deficiency of the enzyme glucocerebrosidase leads to the accumulation of its substrate glucocerebroside throughout the body, primarily in the spleen, liver, and bone marrow. The...

Birtamimab to Treat AL Amyloidosis

Hideki Garren, MD, PHD, Chief Medical Officer at Prothena discusses the clinical data supporting the use of birtamimab to treat AL amyloidosis.     AL amyloidosis is a rare blood disorder associated with the overproduction of amyloid. This leads to the...

Treatment Options for FOP Patients

Mona Al Mukaddam, MD, Associate Professor of Clinical Medicine and Orthopaedic Surgery at Penn Medicine, describes treatment options for persons with fibrodysplasia ossificans progressiva (FOP).     New bone formation outside of the normal skeletal system...